LA HB377

Healthcare providers must give written and verbal notice before administering any drug, vaccine, device, or test that has only FDA Emergency Use Authorization (EUA) and has not received full FDA approval

Required notice must inform patients that the product is EUA-only, that they may refuse without discrimination or loss of services, and must explain known risks, benefits, and alternatives including non-treatment options

Providers must obtain patient signature or electronic acknowledgment confirming receipt of notice, and must document any refusal in the medical record with the date and specific product declined

Patients who refuse EUA products are protected from negative consequences including denial of treatment, loss of employment, or denial of benefits and services

Non-compliant healthcare providers face disciplinary action including license revocation or suspension, fines, or other penalties from their licensing authority